Phillips 66 (PSX) Spending and interest coverage
- R&D / revenue · 12 months: Value 0.00%; Formula and calculation Research and development expense / revenue. Period ending 2025-12-31..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2025-12-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 0.00% | Research and development expense / revenue. Period ending 2025-12-31. $6.00M ÷ $132.38B × 100 ≈ 0.00% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 6.00M USD | Research and Development Expense |
| Revenue | 132.38B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $6.00M | $132.38B | (m) | (m) | (m) | 0.00% | (m) | (m) | (m) |
| 2024-12-31 | $15.00M | $143.15B | (m) | (m) | (m) | 0.01% | (m) | (m) | (m) |
| 2023-12-31 | $27.00M | $147.40B | (m) | (m) | (m) | 0.02% | (m) | (m) | (m) |
| 2022-12-31 | $42.00M | $169.99B | (m) | (m) | (m) | 0.02% | (m) | (m) | (m) |
| 2021-12-31 | $47.00M | $111.48B | (m) | (m) | (m) | 0.04% | (m) | (m) | (m) |
| 2020-12-31 | $48.00M | $64.13B | (m) | (m) | (m) | 0.07% | (m) | (m) | (m) |
| 2019-12-31 | $54.00M | $107.29B | (m) | (m) | (m) | 0.05% | (m) | (m) | (m) |
| 2018-12-31 | $55.00M | $111.46B | (m) | (m) | (m) | 0.05% | (m) | (m) | (m) |
| 2017-12-31 | $60.00M | $102.35B | (m) | (m) | (m) | 0.06% | (m) | (m) | (m) |
| 2016-12-31 | $60.00M | $84.28B | (m) | (m) | (m) | 0.07% | (m) | (m) | (m) |
| 2015-12-31 | $65.00M | $98.97B | (m) | (m) | (m) | 0.07% | (m) | (m) | (m) |
| 2014-12-31 | $62.00M | $161.21B | (m) | (m) | (m) | 0.04% | (m) | (m) | (m) |
| 2013-12-31 | $69.00M | $171.60B | (m) | (m) | (m) | 0.04% | (m) | (m) | (m) |
| 2012-12-31 | $76.00M | $179.46B | (m) | (m) | (m) | 0.04% | (m) | (m) | (m) |
| 2011-12-31 | $74.00M | $196.09B | (m) | (m) | (m) | 0.04% | (m) | (m) | (m) |
| 2010-12-31 | $56.00M | $146.56B | (m) | (m) | (m) | 0.04% | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marathon Petroleum Corp (MPC) | United States | $109.683B | 8.72 |
| VALERO ENERGY CORP/TX (VLO) | United States | $110.282B | 10.72 |
| IMPERIAL OIL LTD (IMO) | $60.241B | ||
| CONOCOPHILLIPS (COP) | United States | $155.399B | 13.45 |
| CVR ENERGY INC (CVI) | United States | $5.161B | 16.17 |
| ICAHN ENTERPRISES L.P. (IEP) | United States | $4.941B | -9.21 |
| Calumet, Inc. /DE (CLMT) | United States | $4.731B | -23.12 |
| Delek US Holdings, Inc. (DK) | United States | $4.096B | 13.87 |
| SunocoCorp LLC (SUNC) | United States | $3.977B | |
| CHEVRON CORP (CVX) | United States | $406.278B | 15.91 |